Gene editing in the context of an increasingly complex genome

Kevin Blighe, Larry DeDionisio, Kathleen Christie, B Chawes, S Shareef, T Kakouli-Duarte, Connie Chao-Shern, V Harding, R S Kelly, J Stebbing, L Castellano, J A Lasky-Su, M. Andrew Nesbit, Tara C. B. Moore

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The reporting of the first draft of the human genome in 2000 brought with it much hope for the future in what was felt as a paradigm shift toward improved health outcomes. Indeed, we have now mapped the majority of variation across human populations with landmark projects such as 1000 Genomes; in cancer, we have catalogued mutations across the primary carcinomas; whilst, for other diseases, we have identified the genetic variants with strongest association. Despite this, we are still awaiting the genetic revolution in healthcare to materialise and translate itself into the health benefits for which we had hoped. A major problem we face relates to our underestimation of the complexity of the genome, and that of biological mechanisms, generally. Fixation on DNA sequence alone and a ‘rigid’ mode of thinking about the genome has meant that the folding and structure of the DNA molecule —and how these relate to regulation— have been underappreciated. Projects like ENCODE have additionally taught us that regulation at the level of RNA is just as important as that at the spatiotemporal level of chromatin.

In this review, we chart the course of the major advances in the biomedical sciences in the era pre- and post the release of the first draft sequence of the human genome, taking a focus on technology and how its development has influenced these. We additionally focus on gene editing via CRISPR/Cas9 as a key technique, in particular its use in the context of complex biological mechanisms. Our aim is to shift the mode of thinking about the genome to that which encompasses a greater appreciation of the folding of the DNA molecule, DNA- RNA/protein interactions, and how these regulate expression and elaborate disease mechanisms.

Through the composition of our work, we recognise that technological improvement is conducive to a greater understanding of biological processes and life within the cell. We believe we now have the technology at our disposal that permits a better understanding of disease mechanisms, achievable through integrative data analyses. Finally, only with greater understanding of disease mechanisms can techniques such as gene editing be faithfully conducted.
LanguageEnglish
Pages595
Number of pages20
JournalBMC Genomics
Volume19
Issue number595
Early online date8 Aug 2018
DOIs
Publication statusE-pub ahead of print - 8 Aug 2018

Fingerprint

Genome
Human Genome
DNA
Clustered Regularly Interspaced Short Palindromic Repeats
RNA
Technology
Biological Phenomena
Insurance Benefits
Chromatin
Carcinoma
Delivery of Health Care
Mutation
Gene Editing
Health
Population
Neoplasms
Proteins

Keywords

  • gene editing
  • genomic complexity
  • genome
  • transcriptome
  • epigenome
  • sequencing technology development
  • complex genetics
  • CRISPR
  • integrated omics

Cite this

Blighe, K., DeDionisio, L., Christie, K., Chawes, B., Shareef, S., Kakouli-Duarte, T., ... Moore, T. C. B. (2018). Gene editing in the context of an increasingly complex genome. BMC Genomics, 19(595), 595. https://doi.org/10.1186/s12864-018-4963-8
Blighe, Kevin ; DeDionisio, Larry ; Christie, Kathleen ; Chawes, B ; Shareef, S ; Kakouli-Duarte, T ; Chao-Shern, Connie ; Harding, V ; Kelly, R S ; Stebbing, J ; Castellano, L ; Lasky-Su, J A ; Nesbit, M. Andrew ; Moore, Tara C. B. / Gene editing in the context of an increasingly complex genome. In: BMC Genomics. 2018 ; Vol. 19, No. 595. pp. 595.
@article{0e45edb8a4b14544bfea598ee3414481,
title = "Gene editing in the context of an increasingly complex genome",
abstract = "The reporting of the first draft of the human genome in 2000 brought with it much hope for the future in what was felt as a paradigm shift toward improved health outcomes. Indeed, we have now mapped the majority of variation across human populations with landmark projects such as 1000 Genomes; in cancer, we have catalogued mutations across the primary carcinomas; whilst, for other diseases, we have identified the genetic variants with strongest association. Despite this, we are still awaiting the genetic revolution in healthcare to materialise and translate itself into the health benefits for which we had hoped. A major problem we face relates to our underestimation of the complexity of the genome, and that of biological mechanisms, generally. Fixation on DNA sequence alone and a ‘rigid’ mode of thinking about the genome has meant that the folding and structure of the DNA molecule —and how these relate to regulation— have been underappreciated. Projects like ENCODE have additionally taught us that regulation at the level of RNA is just as important as that at the spatiotemporal level of chromatin.In this review, we chart the course of the major advances in the biomedical sciences in the era pre- and post the release of the first draft sequence of the human genome, taking a focus on technology and how its development has influenced these. We additionally focus on gene editing via CRISPR/Cas9 as a key technique, in particular its use in the context of complex biological mechanisms. Our aim is to shift the mode of thinking about the genome to that which encompasses a greater appreciation of the folding of the DNA molecule, DNA- RNA/protein interactions, and how these regulate expression and elaborate disease mechanisms.Through the composition of our work, we recognise that technological improvement is conducive to a greater understanding of biological processes and life within the cell. We believe we now have the technology at our disposal that permits a better understanding of disease mechanisms, achievable through integrative data analyses. Finally, only with greater understanding of disease mechanisms can techniques such as gene editing be faithfully conducted.",
keywords = "gene editing, genomic complexity, genome, transcriptome, epigenome, sequencing technology development, complex genetics, CRISPR, integrated omics",
author = "Kevin Blighe and Larry DeDionisio and Kathleen Christie and B Chawes and S Shareef and T Kakouli-Duarte and Connie Chao-Shern and V Harding and Kelly, {R S} and J Stebbing and L Castellano and Lasky-Su, {J A} and Nesbit, {M. Andrew} and Moore, {Tara C. B.}",
year = "2018",
month = "8",
day = "8",
doi = "10.1186/s12864-018-4963-8",
language = "English",
volume = "19",
pages = "595",
journal = "BMC Genomics",
issn = "1471-2164",
publisher = "BioMed Central",
number = "595",

}

Blighe, K, DeDionisio, L, Christie, K, Chawes, B, Shareef, S, Kakouli-Duarte, T, Chao-Shern, C, Harding, V, Kelly, RS, Stebbing, J, Castellano, L, Lasky-Su, JA, Nesbit, MA & Moore, TCB 2018, 'Gene editing in the context of an increasingly complex genome', BMC Genomics, vol. 19, no. 595, pp. 595. https://doi.org/10.1186/s12864-018-4963-8

Gene editing in the context of an increasingly complex genome. / Blighe, Kevin; DeDionisio, Larry; Christie, Kathleen; Chawes, B; Shareef, S; Kakouli-Duarte, T; Chao-Shern, Connie; Harding, V; Kelly, R S; Stebbing, J; Castellano, L; Lasky-Su, J A; Nesbit, M. Andrew; Moore, Tara C. B.

In: BMC Genomics, Vol. 19, No. 595, 08.08.2018, p. 595.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Gene editing in the context of an increasingly complex genome

AU - Blighe, Kevin

AU - DeDionisio, Larry

AU - Christie, Kathleen

AU - Chawes, B

AU - Shareef, S

AU - Kakouli-Duarte, T

AU - Chao-Shern, Connie

AU - Harding, V

AU - Kelly, R S

AU - Stebbing, J

AU - Castellano, L

AU - Lasky-Su, J A

AU - Nesbit, M. Andrew

AU - Moore, Tara C. B.

PY - 2018/8/8

Y1 - 2018/8/8

N2 - The reporting of the first draft of the human genome in 2000 brought with it much hope for the future in what was felt as a paradigm shift toward improved health outcomes. Indeed, we have now mapped the majority of variation across human populations with landmark projects such as 1000 Genomes; in cancer, we have catalogued mutations across the primary carcinomas; whilst, for other diseases, we have identified the genetic variants with strongest association. Despite this, we are still awaiting the genetic revolution in healthcare to materialise and translate itself into the health benefits for which we had hoped. A major problem we face relates to our underestimation of the complexity of the genome, and that of biological mechanisms, generally. Fixation on DNA sequence alone and a ‘rigid’ mode of thinking about the genome has meant that the folding and structure of the DNA molecule —and how these relate to regulation— have been underappreciated. Projects like ENCODE have additionally taught us that regulation at the level of RNA is just as important as that at the spatiotemporal level of chromatin.In this review, we chart the course of the major advances in the biomedical sciences in the era pre- and post the release of the first draft sequence of the human genome, taking a focus on technology and how its development has influenced these. We additionally focus on gene editing via CRISPR/Cas9 as a key technique, in particular its use in the context of complex biological mechanisms. Our aim is to shift the mode of thinking about the genome to that which encompasses a greater appreciation of the folding of the DNA molecule, DNA- RNA/protein interactions, and how these regulate expression and elaborate disease mechanisms.Through the composition of our work, we recognise that technological improvement is conducive to a greater understanding of biological processes and life within the cell. We believe we now have the technology at our disposal that permits a better understanding of disease mechanisms, achievable through integrative data analyses. Finally, only with greater understanding of disease mechanisms can techniques such as gene editing be faithfully conducted.

AB - The reporting of the first draft of the human genome in 2000 brought with it much hope for the future in what was felt as a paradigm shift toward improved health outcomes. Indeed, we have now mapped the majority of variation across human populations with landmark projects such as 1000 Genomes; in cancer, we have catalogued mutations across the primary carcinomas; whilst, for other diseases, we have identified the genetic variants with strongest association. Despite this, we are still awaiting the genetic revolution in healthcare to materialise and translate itself into the health benefits for which we had hoped. A major problem we face relates to our underestimation of the complexity of the genome, and that of biological mechanisms, generally. Fixation on DNA sequence alone and a ‘rigid’ mode of thinking about the genome has meant that the folding and structure of the DNA molecule —and how these relate to regulation— have been underappreciated. Projects like ENCODE have additionally taught us that regulation at the level of RNA is just as important as that at the spatiotemporal level of chromatin.In this review, we chart the course of the major advances in the biomedical sciences in the era pre- and post the release of the first draft sequence of the human genome, taking a focus on technology and how its development has influenced these. We additionally focus on gene editing via CRISPR/Cas9 as a key technique, in particular its use in the context of complex biological mechanisms. Our aim is to shift the mode of thinking about the genome to that which encompasses a greater appreciation of the folding of the DNA molecule, DNA- RNA/protein interactions, and how these regulate expression and elaborate disease mechanisms.Through the composition of our work, we recognise that technological improvement is conducive to a greater understanding of biological processes and life within the cell. We believe we now have the technology at our disposal that permits a better understanding of disease mechanisms, achievable through integrative data analyses. Finally, only with greater understanding of disease mechanisms can techniques such as gene editing be faithfully conducted.

KW - gene editing

KW - genomic complexity

KW - genome

KW - transcriptome

KW - epigenome

KW - sequencing technology development

KW - complex genetics

KW - CRISPR

KW - integrated omics

UR - https://bmcgenomics.biomedcentral.com/track/pdf/10.1186/s12864-018-4963-8

U2 - 10.1186/s12864-018-4963-8

DO - 10.1186/s12864-018-4963-8

M3 - Article

VL - 19

SP - 595

JO - BMC Genomics

T2 - BMC Genomics

JF - BMC Genomics

SN - 1471-2164

IS - 595

ER -

Blighe K, DeDionisio L, Christie K, Chawes B, Shareef S, Kakouli-Duarte T et al. Gene editing in the context of an increasingly complex genome. BMC Genomics. 2018 Aug 8;19(595):595. https://doi.org/10.1186/s12864-018-4963-8